The DCP Study: HCTZ vs Chlorthalidone episode artwork

EPISODE · Jan 30, 2023 · 22 MIN

The DCP Study: HCTZ vs Chlorthalidone

from CEimpact Podcast · host CEimpact

Hydrochlorothiazide is the go-to thiazide for hypertension control despite better data for chlorthalidone. Join host Geoff Wall as he evaluates the new randomized controlled study to determine what is the best thiazide.The GameChangerSeveral pharmacologic differences exist between hydrochlorothiazide and chlorthalidone. The new DCP Study did not find any differences in cardiovascular outcomes.Show Segments00:00 - Introductions02:20 - History of HCTZ vs Chlorthalidone05:26 - The Diuretic Comparison Project: HCTZ vs Chlorthalidone12:27 - The GameChanger: DCP Results19:48 - Connecting to Practice: Choosing Between the Two21:47 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesChlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.Redeem your CPE or CME hereCPE (Pharmacist)CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the pharmacologic differences of hydrochlorothiazide and chlorthalidone2. Apply the results of the DCP Study to clinical practice0.05 CEU/0.5 HrUAN: 0107-0000-23-025-H01-PInitial release date: 01/30/2023Expiration date: 01/30/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Episode metadata supplied by the publisher feed · Published Jan 30, 2023

Embed this episode

Hydrochlorothiazide is the go-to thiazide for hypertension control despite better data for chlorthalidone. Join host Geoff Wall as he evaluates the new randomized controlled study to determine what is the best thiazide. The GameChanger Several pharmacologic differences exist between hydrochlorothiazide and chlorthalidone. The new DCP Study did not find any differences in cardiovascular outcomes. Show Segments 00:00 - Introductions 02:20 - History of HCTZ vs Chlorthalidone 05:26 - The Diuret...

Distinct summary based on available episode metadata or transcript content.

Ready to play

The DCP Study: HCTZ vs Chlorthalidone

0:00 22:17

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of CEimpact Podcast?

This episode is 22 minutes long.

When was this CEimpact Podcast episode published?

This episode was published on January 30, 2023.

Can I download this CEimpact Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!